← Apex Wire
Insider activity — LYELLyell Immunopharma, Inc.

18 Form 4 filings for LYEL between 2026-07-27 and 2026-11-12, from 9 filers. 15 discretionary (13 sales, 2 purchases), 3 routine grant or withholding filings. 15 of 18 carry a dollar total (8 stated, 7 computed as shares × price), summing to $50,233,419; a multi-transaction filing without a stated total contributes only its largest transaction, so the sum is a floor and the true figure is higher. Prices ran $9 to $16.

Filings 18 Filers 9 Discretionary 15 Routine 3 Structured 9/18

Filers
▸Lee Gary K.Chief Scientific Officer 2026-11-12 · sold 129 @ $15.93 for $2,055 TOTAL SOLD ≥ $2,0553 filings
FiledActionShares
largest txn
PriceFiling totalTxnsSEC
2026-11-12 sold 129 $15.93 $2,055 1 RECEIPT ↗
2026-08-25 sold 1,457 $15.54 $22,642 — RECEIPT ↗
2026-08-11 sold 131 $14.34 $1,879 — RECEIPT ↗
▸Hill Stephen J.Chief Operating Officer 2026-11-12 · sold 88 @ $15.93 for $1,402 TOTAL SOLD ≥ $1,4023 filings
FiledActionShares
largest txn
PriceFiling totalTxnsSEC
2026-11-12 sold 88 $15.93 $1,402 1 RECEIPT ↗
2026-08-25 sold 989 $15.54 $15,369 — RECEIPT ↗
2026-08-11 sold 89 $14.34 $1,276 — RECEIPT ↗
▸Seely LynnPresident and CEO 2026-11-12 · sold 545 @ $15.93 for $8,682 TOTAL SOLD ≥ $8,6823 filings
FiledActionShares
largest txn
PriceFiling totalTxnsSEC
2026-11-12 sold 545 $15.93 $8,682 1 RECEIPT ↗
2026-08-25 sold 9,589 $15.54 $149,013 — RECEIPT ↗
2026-08-11 sold 390 $14.34 $5,593 — RECEIPT ↗
▸Bulis Veronica SanchezVP, Corporate Controller 2026-11-12 · sold 416 @ $15.93 for $6,627 TOTAL SOLD ≥ $6,6272 filings
FiledActionShares
largest txn
PriceFiling totalTxnsSEC
2026-11-12 sold 416 $15.93 $6,627 1 RECEIPT ↗
2026-08-11 sold 621 $14.34 $8,905 — RECEIPT ↗
▸ARCH Venture Partners IX, LLC10% Owner 2026-11-05 · purchased (open market) 2,321,262 @ $10.77 for $24,999,992 TOTAL BOUGHT ≥ $24,999,9921 filing
FiledActionShares
largest txn
PriceFiling totalTxnsSEC
2026-11-05 purchased (open market) 2,321,262 $10.77 $24,999,992 1 RECEIPT ↗
▸ARCH Venture Partners XIII, L.P.10% Owner 2026-11-05 · purchased (open market) 2,321,262 @ $10.77 for $24,999,992 TOTAL BOUGHT ≥ $24,999,9921 filing
FiledActionShares
largest txn
PriceFiling totalTxnsSEC
2026-11-05 purchased (open market) 2,321,262 $10.77 $24,999,992 1 RECEIPT ↗
▸Aguirre Jarrad MattieuChief Medical Officer 2026-10-13 · sold 422 @ $8.63 for $3,642 TOTAL SOLD ≥ $3,6422 filings
FiledActionShares
largest txn
PriceFiling totalTxnsSEC
2026-10-13 sold 422 $8.63 $3,642 1 RECEIPT ↗
2026-09-10 received (award/grant) 47,500 — — 1 RECEIPT ↗
▸Shook DavidChief Medical Officer 2026-09-10 · sold 500 @ $12.70 for $6,350 TOTAL SOLD ≥ $6,3501 filing
FiledActionShares
largest txn
PriceFiling totalTxnsSEC
2026-09-10 sold 500 $12.70 $6,350 1 RECEIPT ↗
▸Innovative Cellular Therapeutics Holdings Ltdrole unstated 2026-07-27 2 filings
FiledActionShares
largest txn
PriceFiling totalTxnsSEC
2026-07-27 — 44,000 — — — RECEIPT ↗
2026-07-27 — 38,500 — — — RECEIPT ↗

9 filers · 18 filings · disclosed filing totals sum to $50,233,419 (8/18 state one, 7 computed; totals are proceeds with a floor, never profit — a Form 4 states what was traded, not what it cost the filer)

Elsewhere